These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32585946)

  • 21. Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder.
    Wuerfel E; Bien CG; Vincent A; Woodhall M; Brockmann K
    J Neurol Sci; 2014 Aug; 343(1-2):180-2. PubMed ID: 24880541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of progressive encephalomyelitis with rigidity and myoclonus associated with anti-GAD, anti-glycine receptor and anti-GM1 antibodies].
    Koike Y; Suwabe T; Konno T; Umeda Y; Oyake M; Fujita N
    Rinsho Shinkeigaku; 2015; 55(2):111-4. PubMed ID: 25746075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapidly Progressive Corticobasal Degeneration Mimicking Brainstem Encephalitis.
    Moura J; Oliveira V; Sardoeira A; Pinto M; Gelpi E; Taipa R; Santos E
    Mov Disord Clin Pract; 2023 Feb; 10(2):300-306. PubMed ID: 36825044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children.
    Chan DWS; Thomas T; Lim M; Ling S; Woodhall M; Vincent A
    Eur J Paediatr Neurol; 2017 Mar; 21(2):414-417. PubMed ID: 27653852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
    Lass P; Sławek J; Derejko M; Dubaniewicz M
    Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic delivery of human GlyR IgG antibody induces GlyR internalization into motor neurons of brainstem and spinal cord with motor dysfunction in mice.
    Carvajal-González A; Jacobson L; Clover L; Wickremaratchi M; Shields S; Lang B; Vincent A
    Neuropathol Appl Neurobiol; 2021 Feb; 47(2):316-327. PubMed ID: 32910464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiglycine receptor antibody related disease: a case series and literature review.
    Swayne A; Tjoa L; Broadley S; Dionisio S; Gillis D; Jacobson L; Woodhall MR; McNabb A; Schweitzer D; Tsang B; Vincent A; Irani SR; Wong R; Waters P; Blum S
    Eur J Neurol; 2018 Oct; 25(10):1290-1298. PubMed ID: 29904974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes.
    Zhao P; Zhang B; Gao S
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S60-2. PubMed ID: 22166456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal correlates of clinical asymmetry in progressive supranuclear palsy.
    Amtage F; Hellwig S; Kreft A; Spehl T; Glauche V; Winkler C; Rijntjes M; Hellwig B; Weiller C; Weber WA; Tüscher O; Meyer PT
    Clin Nucl Med; 2014 Apr; 39(4):319-25. PubMed ID: 24566396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical spectrum of anti-glycine receptor antibody-associated disease].
    Iizuka T; Tominaga N; Kaneko J
    Rinsho Shinkeigaku; 2013; 53(11):1063-6. PubMed ID: 24291880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progressive encephalomyelitis with rigidity and myoclonus: anesthesia and glycine receptor antibodies.
    Papadopoulou A; Samuels TL; Dassanayake A; Spring C; Willers J; Uncles DR
    A A Case Rep; 2014 Apr; 2(7):81-2. PubMed ID: 25611646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypothalamic-Bulbar MRI Hyperintensity in Anti-IgLON5 Disease with Serum-Restricted Antibodies: A Case Report and Systematic Review of Literature.
    Tagliapietra M; Frasson E; Cardellini D; Mariotto S; Ferrari S; Zanusso G; Plebani M; Monaco S
    J Alzheimers Dis; 2021; 79(2):683-691. PubMed ID: 33337376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [An 81-year-old woman with progressive motor disturbance, extrapyramidal features, dementia, and oculomotor palsy].
    Urabe T; Mori H; Sumino S; Miwa H; Wakiya M; Shirai T; Takubo H; Mizuno Y
    No To Shinkei; 1998 Mar; 50(3):291-301. PubMed ID: 9566008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancy between clinical and pathological diagnoses of CBD and PSP.
    Mizuno T; Shiga K; Nakata Y; Nagura J; Nakase T; Ueda Y; Takanashi Y; Urasaki K; Oyamada Y; Fushiki S; Nishikawa J; Yasuhara M; Nakajima K; Nakagawa M
    J Neurol; 2005 Jun; 252(6):687-97. PubMed ID: 15754090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
    Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
    Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports.
    Sarva H; Deik A; Ullah A; Severt WL
    Tremor Other Hyperkinet Mov (N Y); 2016; 6():340. PubMed ID: 26989571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.